SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Spartex who wrote (1008)11/3/2005 6:25:49 PM
From: DewDiligence_on_SI  Respond to of 3557
 
I’ve never owned REGN. I was short for a while in 2003 following the Avastin-derived pop.

I followed REGN as a potential competitor in AMD when I was long GENR, which I sold one year ago.

These days, I don’t pay a lot of attention to REGN, but I’m still curious to see if they can get decent results using VEGF Trap in a local formulation for AMD. Regards, Dew